Entries of Zoernig, I. on the publication server

Haag, G. M., Zoernig, I., Hassel, J. C., Halama, N., Dick, J., Lang, N., Podola, L., Funk, J., Ziegelmeier, C., Juenger, S., Bucur, M., Umansky, L., Falk, C. S. , Freitag, A., Karapanagiotou-Schenkel, I., Beckhove, P., Enk, A. and Jaeger, D. (2018) Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1. European Journal of Cancer 90, pp. 122-129. Fulltext not available.